CIDRAP newsletters options
For the first time, children account for more than a quarter of new weekly COVID-19 cases.
Global COVID-19 cases and deaths remain at a high plateau, with the Americas as a hot spot region.
The Centers for Disease Control and Prevention (CDC) today announced the creation of Public Health AmeriCorps through a partnership with the federal agency for volunteering and national service, AmeriCorps. The new program will help recruit, develop, and train new public health leaders.
The Pfizer/BioNTech and Moderna mRNA-based COVID-19 vaccines have a collective 91% vaccine efficacy against SARS-CoV-2 infection in Americans 16 years and older, according to a test-negative study published in the Journal of Infectious Diseases today.
As global cases top 220 million, surges continue in Southeast Asia and Oceania.
About 100,000 Americans are currently hospitalized because of COVID-19.
Study reveals a small link between school closures and worse mental health, particularly in older and minority students.
Results from an observational cohort study of pregnant women indicated a 96% vaccine effectiveness (VE) against COVID-19 infection and an 89% VE against hospitalization for the Pfizer/BioNTech vaccine in pregnant women, according to a study in Nature Medicine today.
A new study by researchers in Pakistan details the impact and response to treatment among children diagnosed as having extensively drug-resistant (XDR) typhoid infections.
The state has stepped into oxygen negotiations, created resource depots, and taken other actions.
Also, Africa is struggling to meet its end-of-September vaccination coverage goal of 10%.
None of the specified outcomes in 6.2 million vaccine recipients met the criteria for a safety signal.
The US surge has driven child COVID-19 hospitalization rates to pandemic highs.
A survey across 73 countries assessing the impact of COVID-19 on the prevention and control of antimicrobial resistance (AMR) highlights reduced availability of nursing, medical, and public health staff for AMR efforts. The study was published today in the Journal of Antimicrobial Chemotherapy.
COVID-19 vaccine effectiveness (VE) against the Delta (B1617.2) variant was 65% in those fully vaccinated, according to a population-based study in Norway. The results, published in Eurosurveillance yesterday, looked at 4,204,859 infected adults without previous COVID-19 from mid-April to mid-August.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
After years of decline, US hospitals saw significant increases in HAIs.
The odds of long COVID-19 fall by more than half after two doses of vaccine.
"A transparent, thorough, and objective review of the data by the FDA is critical."
The ECDC says a third dose should already be considered in the immune-compromised.
